Atom Therapeutics

Hangzhou, China · Founded 2012 · In IPO Registration

Developer and researcher of new drugs and treatments designed to treat metabolic diseases and cancers. Atom Therapeutics is based in Hangzhou, China and was founded in 2012. Its last reported valuation was $425 million in Aug 2025. It has raised $70 million.

Last reported valuation

$425.1M

Oct 2026

Priced at

—

Total raised

$70.0M

Last round

—

How much has Atom Therapeutics raised?

$70.0Macross 0 recorded rounds

Free account

More of Atom Therapeutics with a free account

·The complete investor list: 15 names
·Watch Atom Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Atom Therapeutics investors

15 investors are on record for Atom Therapeutics, including Suzhou Oriza Holdings Corporation, HSG (Hong Kong), Fortune Capital and Shenzhen Yifeng Investment Management Enterprise.

For fundraisers

Raising for a company like Atom Therapeutics?

15 investors have backed Atom Therapeutics.

See all 15 investors →

Frequently asked about Atom Therapeutics

How much has Atom Therapeutics raised?: Atom Therapeutics has raised $70.0M in total across 0 recorded funding rounds.